Korro Bio (NASDAQ:KRRO) Rating Reiterated by HC Wainwright

HC Wainwright reissued their buy rating on shares of Korro Bio (NASDAQ:KRRO – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $100.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. BMO Capital Markets reaffirmed an outperform rating […]

Related Keywords

Canada ,United States ,Korro Bio ,Piper Sandler ,Venture Opportunity Fund Atlas ,Korro Bio Company Profile ,Star Investment Management Corp ,Royal Bank ,Korro Bio Inc ,Nasdaq ,Eventide Asset Management ,Monashee Investment Management ,Atlas Venture Life Science Advisors ,Investment Holdings ,Free Report ,Asset Management ,Investment Management ,Venture Life Science Advisors ,North Star Investment Management ,Get Free Report ,Korro Bio Daily ,